Thyroid carcinoma is rare among human malignancies (! 1%) but is the most frequent
endocrine cancer, accounting for about 5% of thyroid nodules (1). The latter are very …

Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid
cancer (DTC) should be implemented in line with patients' risk stratification. Although …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

THYROID NODULES are a common clinical problem. Epidemiologic studies have shown
the prevalence of palpable thyroid nodules to be approximately 5% in women and 1% in …

THERAPY OF THYROID DISEASE WITH 131I• Silberstein et al. 1633 patients throughout
the United States. Existing practice guidelines will be reviewed for revision or renewal, as …

Theranostics is an emerging paradigm that combines imaging and therapy in order to
personalize patient treatment. In nuclear medicine, this is achieved by using …

Objective Because differentiated (follicular and papillary) thyroid cancer (DTC) may recur
years after initial treatment, the follow-up of patients with DTC is long term. However, this …

The use of radioactive iodine (131 I) for the treatment of thyroid carcinoma has changed over
the past 50 y. These changes are based on increasing awareness of the biophysical …